Report copyright - Pharmakovigilanz und AMTS von oralen Onkologika¼r... · • Dasatinib • Erlotinib • Gefitinib • Lapatinib • Nilotinib • Palbociclib (nPPI 62/80) • Pazopanib • Ribociclib
Please pass captcha verification before submit form
Please pass captcha verification before submit form